Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Preemptive Infusion of Donor Lymphocytes Depleted of TCR (Alpha-beta) + T Cells and CD19+ B Cells Following Allogeneic Stem Cell Transplantation

NCT03939585 is registered in ClinicalTrials.gov with Leland Metheny as lead sponsor.

NCT NCT03939585
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03939585 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Preemptive Infusion of Donor Lymphocytes Depleted of TCR (Alpha-beta) + T Cells and CD19+ B Cells Following Allogeneic Stem Cell Transplantation
Lead sponsor
Leland Metheny
Phase
Phase 1
Overall status
Withdrawn
Start date
December 1, 2024
Completion date
June 1, 2026
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid/lymphoblastic leukemia, allogeneic stem cell transplant candidate, lymphoproliferative disorders, myelodysplastic syndrome, myeloproliferative neoplasm